P1214 SUBCUTANEOUS EPCORITAMAB + R-CHOP FOR FIRST-LINE TREATMENT OF PATIENTS WITH HIGHRISK DIFFUSE LARGE B-CELL LYMPHOMA: PHASE 1/2 UPDATE: Michael Roost Clausen1, Fritz Offner 2, David Belada 3, Joshua Brody4, Kim M. Linton5, Yasmin Karimi 6, Raul Cordoba7, Sylvia Snauwaert 8, Aqeel Abbas 9, Liwei Wang9, Jun Wu10, Brian Elliott 9, Lorenzo Falchi 11

Kim Linton

Research output: Contribution to journal › Conference article › peer-review

Fingerprint

Dive into the research topics of 'P1214 SUBCUTANEOUS EPCORITAMAB + R-CHOP FOR FIRST-LINE TREATMENT OF PATIENTS WITH HIGHRISK DIFFUSE LARGE B-CELL LYMPHOMA: PHASE 1/2 UPDATE: Michael Roost Clausen1, Fritz Offner 2, David Belada 3, Joshua Brody4, Kim M. Linton5, Yasmin Karimi 6, Raul Cordoba7, Sylvia Snauwaert 8, Aqeel Abbas 9, Liwei Wang9, Jun Wu10, Brian Elliott 9, Lorenzo Falchi 11'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science